✦ LIBER ✦

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non-Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial

✍ Scribed by Douillard, J.-Y.; Shepherd, F. A.; Hirsh, V.; Mok, T.; Socinski, M. A.; Gervais, R.; Liao, M.-L.; Bischoff, H.; Reck, M.; Sellers, M. V.; Watkins, C. L.; Speake, G.; Armour, A. A.; Kim, E. S.

Book ID: 118001868
Publisher: American Society of Clinical Oncology
Year: 2010
Tongue: English
Weight: 241 KB
Volume: 28
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2009.24.3030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib versus docetaxel in previously

Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial

✍ Edward S Kim; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Yi-Long Wu; L 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 243 KB

Randomized Phase III Trial of Pemetrexed

Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non-Small-Cell Lung Cancer Previously Treated With Chemotherapy

✍ Hanna, N.; Shepherd, F. A.; Fossella, F. V.; Pereira, J. R.; De Marinis, F.; von 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 229 KB

Review of two phase III randomized trial

Review of two phase III randomized trials of single-agent docetaxel in previously treated advanced non-small cell lung cancer

✍ Thomas J Lynch Jr 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 515 KB

Molecular Predictors of Outcome With Gef

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non-Small-Cell Lung Cancer

✍ Hirsch, F. R.; Varella-Garcia, M.; Bunn, P. A.; Franklin, W. A.; Dziadziuszko, R 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 191 KB

Phase I/II trial of docetaxel and vinore

Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy

✍ Leu, Kirsten M; Kim, KyungMann; Larson, Marilyn; Larson, Martha; Schiller, Joan 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Phase I trial of non-cytotoxic suramin a

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

✍ Elaine T. Lam; Jessie L.- S. Au; Gregory A. Otterson; M. Guillaume Wientjes; Lin 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 422 KB